AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe

Ajanta Pharma elevates Atul Galgalikar as Vice President for international business

Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role

Cipla elevates Manoj Dimri as Group Business Head

Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla

FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year

Oval Fertility and Merck India partner to advance access to high-quality fertility care

Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California

Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials